US PTO reissue strengthens Pfizer's Lipitor patent
18 March 2009
Nancy Faigen
Pfizerhas completed an action to have the US Patent and Trademark Office reissue a patent related to its hypolipaemic, Lipitor. It will be referred to as reissue patent RE40667. The company applied for the reissue patent more than two years ago, in order to correct a technical defect in the '995 enantiomer...
Please Login to read the full article.
18 March 2009
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
NEWS
- Clever Teva’s preemptive Lipitorpedo strikes in battle for hearts and minds
- Judge squashes Mylan's "unripe" suit urging FDA to rule on Ranbaxy's generic Lipitor
- Mylan suit pushes FDA to decide immediately on Ranbaxy ANDA for generic Lipitor
- Pfizer's 'non obvious' Viagra patents good until 2019 to fend off Teva in US
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
